Repository Citation
Gupta, Avni; Williams, Justin; Maxwell, Rose A.; and Kindig, Marilyn, "Local Wound Infiltration With Liposomal Bupivacaine Decreases Post-Cesarean Pain Scores" (2021). Medical Student Research Symposium Abstracts and Posters. 1.
https://corescholar.libraries.wright.edu/msrs/2021/poster_presentations_8/1
Start Date
29-4-2021 7:05 PM
End Date
29-4-2021 7:15 PM
Document Type
Poster
Description
Surgical patients are routinely prescribed opioid analgesics that are strongly associated with drug overdose deaths. Liposomal bupivacaine is a long-acting local anesthetic that received FDA approval in 2011 for local surgical site infiltration to promote post-operative analgesia. This anesthetic has demonstrated an improvement in post-operative pain control in various surgical realms, indicating a decreased need for opiates and subsequently decreased risks. However, few studies have investigated its use at the time of cesarean delivery.
Abstract - Gupta
Additional Files
Gupta_Liposomal_bupivacaine_decreases_pain_scores-abstract-ocr.pdf (96 kB)Abstract - Gupta
Local Wound Infiltration With Liposomal Bupivacaine Decreases Post-Cesarean Pain Scores
Surgical patients are routinely prescribed opioid analgesics that are strongly associated with drug overdose deaths. Liposomal bupivacaine is a long-acting local anesthetic that received FDA approval in 2011 for local surgical site infiltration to promote post-operative analgesia. This anesthetic has demonstrated an improvement in post-operative pain control in various surgical realms, indicating a decreased need for opiates and subsequently decreased risks. However, few studies have investigated its use at the time of cesarean delivery.
